Intermedics 430-07 Bipol Implant Endocard Pac Lead
510(k) K902672
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK902672 | Date1 Mar 1991 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Intermedics 430-07 Bipolar Implant Endocardial Pacemaker Lead is a Permanent Pacemaker Electrode (product code DTB) designed for endocardial implantation. It delivers bipolar pacing signals to the heart muscle, intended for patients with bradycardia or other cardiac rhythm disorders requiring electrical stimulation to maintain proper heart function.
This device is supplied sterile and intended for single-use implantation within the heart’s endocardium. It is classified as a Class III medical device under FDA regulation 870.3680, with an FDA 510(k) clearance (K902672) issued in 1991. The lead is intended for use in cardiovascular procedures and must be handled under sterile conditions prior to implantation.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the primary clinical purpose of the Intermedics 430-07 Bipolar Implant Endocardial Pacemaker Lead, and how does its bipolar design benefit patients?
The Intermedics 430-07 is designed for endocardial implantation to deliver bipolar pacing signals directly to the heart muscle, addressing bradycardia or other cardiac rhythm disorders requiring electrical stimulation. The bipolar design reduces the risk of muscle stimulation outside the pacing target area, improving pacing efficiency and minimizing discomfort for patients by focusing the electrical current more precisely.
Is this device intended for reuse, or is it meant to be implanted as a single-use item? How does this affect handling and storage?
This device is explicitly intended for single-use implantation and is supplied sterile. Because it is not designed for reuse, it must be handled under sterile conditions before implantation, and any unused portions should be discarded according to sterile medical device protocols. Storage should follow manufacturer guidelines to maintain sterility until use.
What regulatory pathway was followed for FDA clearance, and which advisory committee reviewed this submission?
The Intermedics 430-07 received FDA clearance through a Traditional 510(k) pathway (K902672) under the classification of a Class III medical device (870.3680). The submission was reviewed by the Cardiovascular (CV) Advisory Committee, reflecting its use in cardiovascular procedures. The decision was based on substantial equivalence to a predicate device.
Are there multiple models or sizes available for this pacemaker lead, or is this a single standardized design?
The provided data does not specify multiple models or sizes for the Intermedics 430-07 Bipolar Implant Endocardial Pacemaker Lead, implying it is likely offered as a standardized design for endocardial pacing. For exact sizing or variations, refer to the manufacturer’s technical documentation or catalog.